AUPH

Martin Michael Robert

Known title: Chief Business OfficerCIK: 0001837647

Martin Michael Robert's purchase track record

Martin Michael Robert has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
11/7/2022AUPH$155K+80.2%+121.6%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

AUPH Appears in Report on Activist Investor Activity. Aurinia Pharmaceuticals was mentioned among stocks drawing attention from activist investors, according to recent financial news coverage. No specific activist involvement details or corporate action plans were detailed in the report. The stock is currently trading between its 52-week range extremes, with analysts maintaining price targets notably above current levels.

this person other insiders at AUPH

Transaction History

AUPH▲ Buy—
AUPH▲ Buy$155K
AUPH▲ Buy$0
AUPH▼ Sell$58K
AUPH▲ Buy$533K
AUPH▼ Sell$836K
AUPH▼ Sell$325K
AUPH▼ Sell$1.6M
AUPH▼ Sell$306K
AUPH▼ Sell$1.5M
AUPH▲ Buy$144K
AUPH▼ Sell$1.4M
AUPH▲ Buy$40K
AUPH▲ Buy$184K
AUPH▼ Sell$2.1M
AUPH▲ Buy$424K
AUPH▲ Buy$151K
AUPH▼ Sell$271K
AUPH▼ Sell$346K
AUPH▲ Buy$233K
AUPH▼ Sell$654K
AUPH▼ Sell$304K
AUPH▲ Buy$239K
AUPH▲ Buy$144K
AUPH▼ Sell$1.9M
AUPH▲ Buy$133K
AUPH▼ Sell$495K
AUPH▼ Sell$136K
AUPH▼ Sell$401K

We use analytics to understand how market-wall is used. No personal data is sold.